| Metric | Q4 FY26 | Q3 FY26 | Q4 FY25 |
|---|---|---|---|
| Revenue from operations | 26.7 | 0.0 | 0.0 |
| Other income | 0.8 | 0.0 | 0.0 |
| Total income | 27.6 | 0.0 | 0.0 |
| Profit before exceptional items & tax | 1.3 | 0.0 | 0.0 |
| Profit before tax | 1.3 | 0.0 | 0.0 |
| Net profit | 1.0 | 0.0 | 0.0 |
| Operating margin | 4.7% | 0.0% | 0.0% |
A dash means the filing did not report that period; n/m means not meaningful (margin on near-zero revenue). Growth is not shown when either period was a loss. Operating profit excludes other income.
Source
Read the filing ↗
NSE results filing, NSE: NEPHROCARE. Figures extracted from the filing.
Nephro Care India Ltd: key numbers
- Share price
- ₹93.55
- Market cap
- ₹154.2 Cr
- Revenue (annual)
- ₹88.73 Cr
- Net profit (annual)
- ₹3.37 Cr
- P/E (TTM)
- 45.8×Sector 57.8×
- Promoter holding
- 61.71%+0.00% QoQ
- FII holding
- 0.96%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Nephro Care India Ltd
All →
11:57 IST
NSE
Adverse Business Impact
Nephro Care India Adverse Business Impact
Nephro Care India closes its Salt Lake, Kolkata dialysis unit from September 15, 2026 due to licensing constraints. Operations cease and premises will be vacated.
17:20 IST
NSE
Financial Results
Nephro Care India Q1 FY27 Results: Net Profit ₹1.6 Cr, Up 60.0% YoY
Nephro Care India Ltd reported revenue from operations of ₹29.2 Cr (+9.4% YoY) and net profit of ₹1.6 Cr (+60.0% YoY) for Q1 FY27.
- Key figure
- Net profit ₹1.6 Cr · +60.0% YoY